News About: Pharm. Industry
Generic battle seen intensifying
With many global makers' blockbuster products, such as Lipitor, Cozaar and Plavix, coming off patent, the race for the generic drug market is set to be in full force in the first half of this year.
Kiwoom Securitie...
IBM Korea to join BRC project
IBM Korea plans to take an active role in Bio Research Complex (BRC) project in the Incheon Free Economic Zone, along with Gil Hospital.
Leveraging on its superior IT technology the company is looking at creating s...
GSK releases Synflorix, pediatric pneumococcal vaccine, in Korea
GlaxoSmithKline (GSK) said it has supplied to the domestic hospitals and clinics its Synflorix a paediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumoni...
Arnaud named head of Sanofi-Aventis Korea
Sanofi-Aventis Korea appointed Jean-Marie Arnaud as its new chief executive, responsible for taking charge of the Korean subsidiary of the global pharmaceutical company as of August 1, 2010.
He joined Sanofi-Aventi...
Korea emerging as global drug trial hub
Korea is rapidly emerging as a global hub of clinical trials for multinational firms thanks to its excellent infrastructure for clinical research, the Ministry of Health, Welfare and Family Affairs said on July 25.
...
Scrapping of unified distribution system is hot potato
All wholesalers have been making all-outs to delay the scrapping of controversial unified distribution system as it links to their survival.
The government said it will allow hospitals with more than 100 beds to ma...
Patrick Holt named Allergan Korea
Patrick Holt, ex-executive of MSD Korea, has been recently made Allergan Korea's president and CEO to head the local operation.
Holt will now oversee the company's overall sales and marketing business, Allergan Kor...
Periodic Safety Update Report system draws varying reactions
Pharmaceutical companies have disclosed varying views with reference to Periodic Safety Update Reports (PSUR) the Korea Food and Drug Administration aims to introduce as part of its efforts to provide an update of the...
Huons, CTBio to develop medication for premature ejaculation (PE)
Huons Co. said it will conduct its phase 2b clinical trial for a novel drug for the treatment of premature ejaculation (PE) under the joint collaboration with CTBio as part of its plan to commercialize the mediation i...
Indian generic giants to get easier access to Korean pharmaceutical market
Influenced by the government’s firm determination to stamp out illegal rebate here, Indian generic markers are poised to enter the Korean pharmaceutical market as situation will permit.
"If Cipla makes good busines...
